IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bridger Management, LLC

Q4 2023 Holdings

Filed 2024-02-14 | 2 holdings | $1.3M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2024-03-25) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Uber Technologies Inc(UBER)COM90353T100$27.4M445,35710.6%
Godaddy Inc(GDDY)CL A380237107$25.1M236,2449.7%
Caesars Entertainment Inc NE(CZR)COM12769G100$20.1M427,9257.7%
Vertex Pharmaceuticals Inc(VRTX)COM92532F100$19.5M48,0007.5%
Morgan Stanley(MS)COM NEW617446448$17.0M181,9146.5%
ELI Lilly & Co(LLY)COM532457108$16.4M28,0766.3%
Teva Pharmaceutical Inds LTD(TEVA)SPONSORED ADS881624209$15.7M1,500,0006.0%
Bath & Body Works Inc(BBWI)COM070830104$14.3M332,3275.5%
US Foods Hldg Corp(USFD)COM912008109$14.2M312,3315.5%
Endeavor Group Hldgs Inc(0C3)CL A COM29260Y109$10.4M436,8604.0%
Charter Communications Inc N(CHTR)CL A16119P108$10.3M26,5134.0%
Pfizer Inc(PFE)COM717081103$10.1M350,5003.9%
Docebo Inc(DCBO)COM25609L105$9.3M192,8923.6%
Crown Hldgs Inc(CCK)COM228368106$9.1M99,0003.5%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$6.8M146,8002.6%
Quanterix Corp(QTRX)COM74766Q101$4.2M154,9001.6%
Springworks Therapeutics IncCOM85205L107$3.7M101,1261.4%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$3.7M117,3411.4%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$3.6M18,9221.4%
Williams Rowland AcquisitionCOM96951B102$3.1M297,0001.2%
Atricure Inc(ATRC)COM04963C209$3.1M87,1001.2%
Catalyst Pharmaceuticals Inc(CPRX)COM14888U101$3.1M184,5271.2%
Uniqure NV(QURE)SHSN90064101$2.5M362,3490.9%
Alphabet Inc(GOOGL)CAP STK CL A02079K305$1.9M13,9000.7%
Melco Resorts and Entmnt LTD(MLCO)ADR585464100$1.9M214,7630.7%
Cytokinetics Inc(CYTK)COM NEW23282W605$1.9M22,5100.7%
Microsoft Corp(MSFT)COM594918104$1.2M3,2750.5%
Toast Inc(TOST)ACL A888787108$962.2K52,69274.8%
Nextdecade Corp(NEXT)ACOM65342K105$323.6K67,83725.2%
Surrozen Inc(SRZNW)*W EXP 08/01/20386889P117$9.1K466,6660.0%